Il y a eu 50 transactions d'initiés récentes enregistrées pour Viridian Therapeutics, Inc. (VRDN), dont 31 achats et 13 ventes. Le total des achats d'initiés s'élève à $70.08M et le total des ventes d'initiés à $4.81M.
Les initiés notables ayant une activité récente comprennent Beetham Thomas W., Mahoney Stephen F., Harmon Seth. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — VRDN
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retenue Fiscale RSU |
3,138 |
$29.32 |
$92.01K |
13,271 |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retenue Fiscale RSU |
7,627 |
$29.32 |
$223.62K |
33,130 |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retenue Fiscale RSU |
2,091 |
$29.32 |
$61.31K |
7,790 |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retenue Fiscale RSU |
1,724 |
$29.32 |
$50.55K |
3,445 |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retenue Fiscale RSU |
3,048 |
$30.19 |
$92.02K |
13,361 |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retenue Fiscale RSU |
7,408 |
$30.19 |
$223.65K |
33,349 |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retenue Fiscale RSU |
2,031 |
$30.19 |
$61.32K |
7,850 |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retenue Fiscale RSU |
1,675 |
$30.19 |
$50.57K |
3,494 |
| 2026-03-02 |
Beetham Thomas W. |
Chief Operating Officer |
Attribution de RSU |
35,300 |
- |
- |
35,300 |
| 2026-03-02 |
Mahoney Stephen F. |
President and CEO |
Attribution de RSU |
111,900 |
- |
- |
111,900 |
| 2026-03-02 |
Tripuraneni Radhika |
Chief Medical Officer |
Attribution de RSU |
19,150 |
- |
- |
19,150 |
| 2026-03-02 |
Harmon Seth |
Chief Financial Officer |
Attribution de RSU |
20,550 |
- |
- |
20,550 |
| 2026-03-02 |
Tousignant Jennifer |
Chief Legal Officer |
Attribution de RSU |
23,850 |
- |
- |
23,850 |
| 2025-12-31 |
Tousignant Jennifer |
Chief Legal Officer |
Vente Informative |
2,272 |
$31.16 |
$70.8K |
- |
| 2025-10-23 |
Fairmount Funds Management Llc |
10 Percent Owner |
Achat Informatif |
454,545 |
$22.00 |
$10M |
3,914,458 |
| 2025-07-01 |
Morris Arlene |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Ajer Jeffrey Robert |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Moses Jennifer K. |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Cain Christopher W. |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Kiselak Tomas |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Gheuens Sarah |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-06-10 |
Fairmount Funds Management Llc |
10 Percent Owner |
Exercice d'Options (Vente) |
12,500 |
$12.31 |
$153.88K |
- |
| 2025-06-09 |
Fairmount Funds Management Llc |
10 Percent Owner |
Exercice d'Options (Vente) |
1,600 |
$7.80 |
$12.48K |
- |
| 2025-04-07 |
Ajer Jeffrey Robert |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-04-07 |
Ajer Jeffrey Robert |
Director |
Attribution de RSU |
42,000 |
$11.78 |
$494.76K |
42,000 |
| 2025-03-10 |
Tripuraneni Radhika |
Chief Medical Officer |
Inconnu |
40,000 |
$13.21 |
$528.4K |
- |
| 2025-03-10 |
Tripuraneni Radhika |
Chief Medical Officer |
Attribution de RSU |
310,700 |
$15.58 |
$4.84M |
310,700 |
| 2025-03-10 |
Cain Christopher W. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-03-10 |
Cain Christopher W. |
Director |
Attribution de RSU |
42,000 |
$15.58 |
$654.36K |
42,000 |
| 2025-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Attribution de RSU |
37,636 |
- |
- |
37,636 |
| 2025-03-03 |
Mahoney Stephen F. |
President and CEO |
Attribution de RSU |
73,428 |
- |
- |
73,428 |
| 2025-03-03 |
Harmon Seth |
Chief Financial Officer |
Attribution de RSU |
25,068 |
- |
- |
25,068 |
| 2025-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Attribution de RSU |
20,679 |
- |
- |
20,679 |
| 2025-03-03 |
Harmon Seth |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-03-03 |
Tousignant Jennifer |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-09-27 |
Beetham Thomas W. |
Chief Operating Officer |
Achat Informatif |
5,000 |
$23.41 |
$117.05K |
6,000 |
| 2024-09-27 |
Mahoney Stephen F. |
President and CEO |
Achat Informatif |
21,400 |
$23.33 |
$499.26K |
21,400 |
| 2024-09-13 |
Fairmount Funds Management Llc |
10 Percent Owner |
Achat Informatif |
1,600,000 |
$18.75 |
$30M |
3,445,813 |
| 2024-06-26 |
Morris Arlene |
Director |
Attribution de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Harwin Peter Evan |
Director |
Attribution de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Moses Jennifer K. |
Director |
Attribution de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Kiselak Tomas |
Director |
Attribution de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Gheuens Sarah |
Director |
Attribution de RSU |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-03-28 |
Fairmount Funds Management Llc |
10 Percent Owner |
Autre (Vente) |
5,859 |
- |
- |
- |
| 2024-02-12 |
Tousignant Jennifer |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-02-12 |
Tousignant Jennifer |
Chief Legal Officer |
Attribution de RSU |
290,000 |
$19.68 |
$5.71M |
290,000 |
| 2024-02-05 |
Ciulla Thomas |
Chief Medical Officer |
Attribution de RSU |
50,000 |
$18.70 |
$935K |
50,000 |
| 2024-01-22 |
Fairmount Funds Management Llc |
10 Percent Owner, Other: See Remarks |
Achat Informatif |
476,190 |
$21.00 |
$10M |
1,839,954 |
| 2024-01-03 |
Ciulla Thomas |
Chief Medical Officer |
Cession |
270,000 |
$13.76 |
$3.72M |
- |
| 2023-11-10 |
Harmon Seth |
See Remarks |
Attribution de RSU |
270,000 |
$13.76 |
$3.72M |
270,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
